Nexalin Technology NXL
NASDAQ NXL
$4.85 -0.20 (-3.96%)
As of: Sep 10, 2026 · 3:47 PM EDT

Nexalin Technology (NXL) Liabilities and Shareholders Equity (2021 - 2026)

Nexalin Technology (NXL) posted Liabilities and Shareholders Equity of $3.0 million for Q2 2026, down 18.69% on a QoQ basis from $3.7 million in Q1 2026, and down 54.23% year-over-year from $6.6 million in Q2 2025.

Analysis

Nexalin Technology (NXL) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Nexalin Technology has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $3.0 million in Q2 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 54.23% year-over-year to $3.0 million in Q2 2026; TTM through Jun 2026 was $16.5 million, a 13.11% decrease from a year earlier, with the FY2025 full-year figure at $4.6 million, up 9.77% from the prior year.
  • Liabilities and Shareholders Equity was $3.0 million for Q2 2026 at Nexalin Technology, down from $3.7 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $8.4 million in Q3 2022, with the low at $1.6 million in Q2 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $4.7 million, with a median of $4.5 million recorded in 2023.
  • The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity surged 886.09% in 2022, then tumbled 69.8% in 2024.
  • Over 5 years, Liabilities and Shareholders Equity stood at $7.4 million in 2022, then sank by 51.13% to $3.6 million in 2023, then climbed by 16.27% to $4.2 million in 2024, then advanced by 9.77% to $4.6 million in 2025, then tumbled by 35.19% to $3.0 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $3.0 million (Q2 2026), $3.7 million (Q1 2026), and $4.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 179.84 Bn 174.23 Bn 7.27 Bn 109.22 Bn
2 Intuitive Surgical 128.02 Bn 122.81 Bn 1.96 Bn 20.88 Bn
3 Medtronic 117.28 Bn 108.46 Bn 6.34 Bn 93.31 Bn
4 Stryker 103.92 Bn 100.44 Bn 4.50 Bn 47.93 Bn
5 Boston Scientific 63.51 Bn 62.97 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.96 Bn 45.70 Bn 1.35 Bn 13.87 Bn
7 Alcon 32.86 Bn 31.40 Bn 1.68 Bn 31.10 Bn
8 Dexcom 32.25 Bn 30.30 Bn 830.00 Mn 6.46 Bn
9 Steris 20.74 Bn 20.26 Bn 684.20 Mn 10.74 Bn
10 Nexalin Technology 3.42 Mn 2.41 Mn 8,897.00 3.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.00 Mn
Mar 31, 2026 3.69 Mn
Dec 31, 2025 4.64 Mn
Sep 30, 2025 5.13 Mn
Jun 30, 2025 6.56 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 4.22 Mn
Sep 30, 2024 5.26 Mn
Jun 30, 2024 1.56 Mn
Mar 31, 2024 2.83 Mn
Dec 31, 2023 3.63 Mn
Sep 30, 2023 4.43 Mn
Jun 30, 2023 5.18 Mn
Mar 31, 2023 5.93 Mn
Dec 31, 2022 7.43 Mn
Sep 30, 2022 8.35 Mn
Dec 31, 2021 753,698.00